Literature DB >> 817914

Hyperalaninemia hyperpyruvicemia and lactic acidosis due to pyruvate carboxylase deficiency of the liver; treatment with thiamine and lipoic acid.

H Maesaka, K Komiya, K Misugi, K Tada.   

Abstract

A 16-month-old female infant with severe mental and motor retardation, clinically diagnosed as Leigh's encephalomyelopathy, forms the basis of this study. This infant was found to have lactic acidosis, low cerebrospinal fluid glucose, hyperalaninemia, and increased levels of urine lactate, pyruvate and alanine. These laboratory studies suggested an inborn error in gluconeogenesis. Further investigation revealed a low level of hepatic pyruvate carboxylase activity. The patient's elder sister who also had mental and motor deterioration was then also found to have an elevated blood lactate. These two siblings clinically and biochemically showed improvement with treatment consisting of thiamine and lipoic acid.

Entities:  

Mesh:

Substances:

Year:  1976        PMID: 817914     DOI: 10.1007/BF00466274

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  16 in total

1.  Subacute necrotizing encephalomyelopathy (Leigh's disease): a consideration of clinical features and etiology.

Authors:  J H Pincus
Journal:  Dev Med Child Neurol       Date:  1972-02       Impact factor: 5.449

2.  Biochemical studies and therapy in subacute necrotizing encephalomyelopathy (Leigh's syndrome).

Authors:  W D Grover; V H Auerbach; M S Patel
Journal:  J Pediatr       Date:  1972-07       Impact factor: 4.406

3.  Subacute necrotizing encephalomyelopathy with vacuolated cells in the bone marrow.

Authors:  A P Simopoulos; J A Roth; D W Golde; F C Bartter
Journal:  Neurology       Date:  1972-12       Impact factor: 9.910

4.  The effect of thiamine treatment on the activity of pyruvate dehydrogenase: relation of the treatment of Leigh's encephalomyelopathy.

Authors:  F A Hommes; R Berger; G Luit-de-Haan
Journal:  Pediatr Res       Date:  1973-07       Impact factor: 3.756

5.  Leigh's encephalomyelopathy: an inborn error of gluconeogenesis.

Authors:  F A Hommes; H A Polman; J D Reerink
Journal:  Arch Dis Child       Date:  1968-08       Impact factor: 3.791

6.  Leigh's subacute necrotizing encephalopathy: clinical and biochemical study, with special reference to therapy with lipoate.

Authors:  B E Clayton; R H Dobbs; A D Patrick
Journal:  Arch Dis Child       Date:  1967-10       Impact factor: 3.791

7.  Subacute necrotizing encephalomyelopathy. Effects of thiamine and thiamine propyl disulfide.

Authors:  J H Pincus; J R Cooper; Y Itokawa; M Gumbinas
Journal:  Arch Neurol       Date:  1971-06

8.  Pathogenesis of Leigh's encephalomyelopathy.

Authors:  T T Tang; T A Good; P R Dyken; S D Johnsen; S R McCreadie; S T Sy; H A Lardy; F B Rudolph
Journal:  J Pediatr       Date:  1972-07       Impact factor: 4.406

9.  Experience with phosphoryl transferase inhibition in subacute necrotizing encephalomyelopathy.

Authors:  J R Cooper; J H Pincus; Y Itokawa; K Piros
Journal:  N Engl J Med       Date:  1970-10-08       Impact factor: 91.245

10.  A defect in pyruvate decarboxylase in a child with an intermittent movement disorder.

Authors:  J P Blass; J Avigan; B W Uhlendorf
Journal:  J Clin Invest       Date:  1970-03       Impact factor: 14.808

View more
  9 in total

1.  Treatment of chronic congenital lactic acidosis by oral administration of dichloroacetate.

Authors:  Y Kuroda; M Ito; K Toshima; E Takeda; E Naito; T J Hwang; T Hashimoto; M Miyao; M Masuda; K Yamashita
Journal:  J Inherit Metab Dis       Date:  1986       Impact factor: 4.982

2.  Congenital lactic acidosis due to pyruvate carboxylase deficiency: absence of an inhibitor of TPP-ATP phosphoryl transferase.

Authors:  K Tada; G Takada; K Omura; Y Itokawa
Journal:  Eur J Pediatr       Date:  1978-01-17       Impact factor: 3.183

Review 3.  The biotin-dependent carboxylase deficiencies.

Authors:  B Wolf; G L Feldman
Journal:  Am J Hum Genet       Date:  1982-09       Impact factor: 11.025

4.  Leigh's disease with decreased activities of pyruvate carboxylase and pyruvate decarboxylase.

Authors:  J P Van Biervliet; M Duran; S K Wadman; J F Koster; A van Rossum
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

Review 5.  Therapy of mitochondrial disorders.

Authors:  H Przyrembel
Journal:  J Inherit Metab Dis       Date:  1987       Impact factor: 4.982

6.  Lipoic (thioctic) acid increases brain energy availability and skeletal muscle performance as shown by in vivo 31P-MRS in a patient with mitochondrial cytopathy.

Authors:  B Barbiroli; R Medori; H J Tritschler; T Klopstock; P Seibel; H Reichmann; S Iotti; R Lodi; P Zaniol
Journal:  J Neurol       Date:  1995-07       Impact factor: 4.849

7.  Is pyruvate carboxylase involved in the renal tubular reabsorption of bicarbonate?

Authors:  N R Buist
Journal:  J Inherit Metab Dis       Date:  1980       Impact factor: 4.982

8.  Evidence for two genetic complementation groups in pyruvate carboxylase-deficient human fibroblast cell lines.

Authors:  G L Feldman; B Wolf
Journal:  Biochem Genet       Date:  1980-06       Impact factor: 1.890

9.  Clinical exome sequencing reveals a mutation in PDHA1 in Leigh syndrome: A case of a Chinese boy with lethal neuropathy.

Authors:  Ke Gong; Li Xie; Zhong-Shi Wu; Xia Xie; Xing-Xing Zhang; Jin-Lan Chen
Journal:  Mol Genet Genomic Med       Date:  2021-03-04       Impact factor: 2.183

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.